Prognostic Significance of CD27 and CD56 on Newly Diagnosed MM Patients Treated with Bortezomib / 中国实验血液学杂志
Journal of Experimental Hematology
;
(6): 827-831, 2021.
Article
in Chinese
| WPRIM
| ID: wpr-880154
ABSTRACT
OBJECTIVE@#To investigate the significance of CD27 and CD56 in the prognosis of multiple myeloma (MM) patients, and to establish a simple and convenient prognostic risk score.@*METHODS@#One hundred and eleven newly diagnosed MM patients treated by bortezomib in Shengjing hospital from January 1, 2013 to January 1, 2019 were selected, and the relationship between clinical characteristics and survival time of patients was analyzed.@*RESULTS@#The overall survival (OS) of patients in CD27@*CONCLUSION@#Among patients with MM treated by bortezomib, CD27
Full text:
Available
Index:
WPRIM (Western Pacific)
Main subject:
Prognosis
/
Retrospective Studies
/
Hematopoietic Stem Cell Transplantation
/
CD56 Antigen
/
Bortezomib
/
Multiple Myeloma
Type of study:
Observational study
/
Prognostic study
Limits:
Humans
Language:
Chinese
Journal:
Journal of Experimental Hematology
Year:
2021
Type:
Article
Similar
MEDLINE
...
LILACS
LIS